세계의 지카바이러스 검사 시장 : 산업 규모, 점유율, 동향, 기회, 예측 - 검사 유형별(핵산 증폭 검사(NAAT), 혈청학적 검사), 지역별, 경쟁별(2020-2030년)

The Global Zika Virus Testing Market was valued at USD 162.23 million in 2024 and is expected to grow at a CAGR of 6.42% through 2030. This market focuses on diagnostic technologies used to detect the Zika virus, a mosquito-borne pathogen known for its association with severe health outcomes, especially congenital defects in infants born to infected mothers. Testing methods include molecular diagnostics such as PCR, serological assays, and rapid diagnostic tests. Demand for these solutions intensifies during regional outbreaks, often prompting swift public health responses. Rising awareness of Zika's impact on maternal and neonatal health and global efforts to enhance infectious disease preparedness contribute to steady market expansion. Institutions like the CDC highlight the critical importance of early detection, particularly during early pregnancy, when the virus poses the highest risk. The sector is poised for continued growth as surveillance, public health infrastructure, and diagnostic innovation evolve to address emerging vector-borne threats.

Key Market Drivers

Zika Virus Outbreaks

Zika virus outbreaks play a pivotal role in driving the global demand for Zika virus testing. These outbreaks, typically concentrated in areas prone to mosquito-borne illnesses, create urgent public health challenges, triggering widespread diagnostic initiatives. The rapid transmission of the virus via the Aedes mosquito and its association with severe complications like microcephaly in newborns heighten the necessity for early and accurate detection. According to the CDC, first-trimester infections carry the highest risk, with 8% of affected pregnancies in U.S. regions leading to related birth defects. In response, health agencies deploy robust testing strategies aimed at curbing the spread and safeguarding at-risk populations. These efforts, often coordinated through government and international partnerships, lead to temporary surges in testing volumes and drive investment in diagnostics. The market's responsiveness to such health crises ensures its ongoing relevance and integration into emergency preparedness frameworks globally.

Key Market Challenges

Competition from Other Infectious Diseases

The Zika Virus Testing Market faces considerable challenges due to competing priorities in infectious disease management. Resources, funding, and healthcare attention are often directed toward higher-profile or more widespread diseases such as HIV/AIDS, tuberculosis, malaria, or emerging threats like COVID-19. This competition can limit the allocation of critical infrastructure and support for Zika-specific testing, slowing innovation, limiting deployment, and reducing public awareness. As healthcare systems balance multiple disease burdens, Zika testing may receive less focus unless an outbreak occurs, making sustained growth difficult. Ensuring Zika remains on the global health agenda requires coordinated efforts among governments, health organizations, and diagnostics companies to maintain testing readiness and infrastructure.

Key Market Trends

Global Surveillance Networks

A major trend shaping the Global Zika Virus Testing Market is the development and expansion of global surveillance networks. These collaborative systems integrate data collection, diagnostic standardization, and real-time information exchange to monitor the spread of the Zika virus. By fostering international cooperation, these networks enable timely identification of high-risk zones and facilitate proactive deployment of testing resources. Key components include harmonized testing protocols, shared insights on mosquito vectors, and integration with public health strategies. These surveillance systems not only enhance the responsiveness of testing operations but also influence diagnostic demand and guide investment in research. The strengthening of such global monitoring infrastructure supports early detection and containment, reinforcing the importance of diagnostic tools in managing vector-borne disease outbreaks.

Key Market Players

• Quest Diagnostics, Inc.
• Chembio Diagnostic Systems, Inc.
• Biocan Diagnostics, Inc.
• DiaSorin S.p.A.
• F. Hoffmann-La Roche Ltd.
• Siemens Healthineers AG
• SD Biosensors, Inc.

Report Scope:

In this report, the Global Zika Virus Testing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Zika Virus Testing Market, By Test Type:

• Nucleic Acid Amplification Testing (NAAT)
• Serological Testing

Zika Virus Testing Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Zika Virus Testing Market.

Available Customizations:

Global Zika Virus Testing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Types
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Zika Virus Testing Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Test Type (Nucleic Acid Amplification Testing (NAAT), Serological Testing)
  • 5.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
  • 5.2.3. By Company (2024)
• 5.3. Test Type Market Map
  • 5.3.1. By Test Type
  • 5.3.2. By Region

6. North America Zika Virus Testing Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Test Type
  • 6.2.2. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Zika Virus Testing Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Test Type
  • 6.3.2. Canada Zika Virus Testing Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Test Type
  • 6.3.3. Mexico Zika Virus Testing Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Test Type

7. Europe Zika Virus Testing Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Test Type
  • 7.2.2. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Zika Virus Testing Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Test Type
  • 7.3.2. France Zika Virus Testing Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Test Type
  • 7.3.3. United Kingdom Zika Virus Testing Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Test Type
  • 7.3.4. Italy Zika Virus Testing Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Test Type
  • 7.3.5. Spain Zika Virus Testing Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Test Type

8. Asia-Pacific Zika Virus Testing Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Test Type
  • 8.2.2. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Zika Virus Testing Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Test Type
  • 8.3.2. Japan Zika Virus Testing Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Test Type
  • 8.3.3. India Zika Virus Testing Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Test Type
  • 8.3.4. South Korea Zika Virus Testing Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Test Type
  • 8.3.5. Australia Zika Virus Testing Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Test Type

9. South America Zika Virus Testing Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Test Type
  • 9.2.2. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Zika Virus Testing Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Test Type
  • 9.3.2. Argentina Zika Virus Testing Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Test Type
  • 9.3.3. Colombia Zika Virus Testing Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Test Type

10. Middle East and Africa Zika Virus Testing Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Test Type
  • 10.2.2. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. UAE Zika Virus Testing Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Test Type
  • 10.3.2. Saudi Arabia Zika Virus Testing Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Test Type
  • 10.3.3. South Africa Zika Virus Testing Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Test Type

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition
• 12.2. Test Type Development
• 12.3. Recent Developments

13. Porter's analysis

14. PESTEL analysis

15. Competitive Landscape

• 15.1. Quest Diagnostics, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Test Types & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
• 15.2. Chembio Diagnostic Systems, Inc.
• 15.3. Biocan Diagnostics, Inc.
• 15.4. DiaSorin S.p.A.
• 15.5. F. Hoffmann-La Roche Ltd.
• 15.6. Siemens Healthineers AG
• 15.7. SD Biosensors, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer